Cargando…

Identification of pyroptosis‐related lncRNAs for constructing a prognostic model and their correlation with immune infiltration in breast cancer

The inflammasome‐dependent cell death, which is denoted as pyroptosis, might be abnormally regulated during oncogenesis and tumour progression. Long non‐coding RNAs (LncRNAs) are pivotal orchestrators in breast cancer (BC), which have the potential to be a biomarker for BC diagnosis and therapy. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Wenchang, Tan, Yufang, Zhao, Chongru, Wang, Yichen, Wu, Min, Wu, Yiping, Ren, Yuping, Zhang, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581320/
https://www.ncbi.nlm.nih.gov/pubmed/34632690
http://dx.doi.org/10.1111/jcmm.16969
_version_ 1784596781482377216
author Lv, Wenchang
Tan, Yufang
Zhao, Chongru
Wang, Yichen
Wu, Min
Wu, Yiping
Ren, Yuping
Zhang, Qi
author_facet Lv, Wenchang
Tan, Yufang
Zhao, Chongru
Wang, Yichen
Wu, Min
Wu, Yiping
Ren, Yuping
Zhang, Qi
author_sort Lv, Wenchang
collection PubMed
description The inflammasome‐dependent cell death, which is denoted as pyroptosis, might be abnormally regulated during oncogenesis and tumour progression. Long non‐coding RNAs (LncRNAs) are pivotal orchestrators in breast cancer (BC), which have the potential to be a biomarker for BC diagnosis and therapy. The present study aims to explore the correlation between pyroptosis‐related lncRNAs and BC prognosis. In this study, a profile of 8 differentially expressed lncRNAs was screened in the TCGA database and used to construct a prognostic model. The BC patients were divided into high‐ and low‐risk groups dependent on the median cutoff of the risk score in the model. Interestingly, the risk model significantly distinguished the clinical characteristics of BC patients between high‐ and low‐risk groups. Then, the risk score of the model was identified to be an excellent independent prognostic factor. Notably, the GO, KEGG, GSEA and ssGSEA analyses revealed the different immune statuses between the high‐ and low‐risk groups. Particularly, the 8 lncRNAs expressed differentially in BC tissues between two risk subgroups in vitro validation. Collectively, this constructed well‐validated model is of high effectiveness to predict the prognosis of BC, which will provide novel means that is applicable for BC prognosis recognition.
format Online
Article
Text
id pubmed-8581320
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85813202021-11-17 Identification of pyroptosis‐related lncRNAs for constructing a prognostic model and their correlation with immune infiltration in breast cancer Lv, Wenchang Tan, Yufang Zhao, Chongru Wang, Yichen Wu, Min Wu, Yiping Ren, Yuping Zhang, Qi J Cell Mol Med Original Articles The inflammasome‐dependent cell death, which is denoted as pyroptosis, might be abnormally regulated during oncogenesis and tumour progression. Long non‐coding RNAs (LncRNAs) are pivotal orchestrators in breast cancer (BC), which have the potential to be a biomarker for BC diagnosis and therapy. The present study aims to explore the correlation between pyroptosis‐related lncRNAs and BC prognosis. In this study, a profile of 8 differentially expressed lncRNAs was screened in the TCGA database and used to construct a prognostic model. The BC patients were divided into high‐ and low‐risk groups dependent on the median cutoff of the risk score in the model. Interestingly, the risk model significantly distinguished the clinical characteristics of BC patients between high‐ and low‐risk groups. Then, the risk score of the model was identified to be an excellent independent prognostic factor. Notably, the GO, KEGG, GSEA and ssGSEA analyses revealed the different immune statuses between the high‐ and low‐risk groups. Particularly, the 8 lncRNAs expressed differentially in BC tissues between two risk subgroups in vitro validation. Collectively, this constructed well‐validated model is of high effectiveness to predict the prognosis of BC, which will provide novel means that is applicable for BC prognosis recognition. John Wiley and Sons Inc. 2021-10-10 2021-11 /pmc/articles/PMC8581320/ /pubmed/34632690 http://dx.doi.org/10.1111/jcmm.16969 Text en © 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Lv, Wenchang
Tan, Yufang
Zhao, Chongru
Wang, Yichen
Wu, Min
Wu, Yiping
Ren, Yuping
Zhang, Qi
Identification of pyroptosis‐related lncRNAs for constructing a prognostic model and their correlation with immune infiltration in breast cancer
title Identification of pyroptosis‐related lncRNAs for constructing a prognostic model and their correlation with immune infiltration in breast cancer
title_full Identification of pyroptosis‐related lncRNAs for constructing a prognostic model and their correlation with immune infiltration in breast cancer
title_fullStr Identification of pyroptosis‐related lncRNAs for constructing a prognostic model and their correlation with immune infiltration in breast cancer
title_full_unstemmed Identification of pyroptosis‐related lncRNAs for constructing a prognostic model and their correlation with immune infiltration in breast cancer
title_short Identification of pyroptosis‐related lncRNAs for constructing a prognostic model and their correlation with immune infiltration in breast cancer
title_sort identification of pyroptosis‐related lncrnas for constructing a prognostic model and their correlation with immune infiltration in breast cancer
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581320/
https://www.ncbi.nlm.nih.gov/pubmed/34632690
http://dx.doi.org/10.1111/jcmm.16969
work_keys_str_mv AT lvwenchang identificationofpyroptosisrelatedlncrnasforconstructingaprognosticmodelandtheircorrelationwithimmuneinfiltrationinbreastcancer
AT tanyufang identificationofpyroptosisrelatedlncrnasforconstructingaprognosticmodelandtheircorrelationwithimmuneinfiltrationinbreastcancer
AT zhaochongru identificationofpyroptosisrelatedlncrnasforconstructingaprognosticmodelandtheircorrelationwithimmuneinfiltrationinbreastcancer
AT wangyichen identificationofpyroptosisrelatedlncrnasforconstructingaprognosticmodelandtheircorrelationwithimmuneinfiltrationinbreastcancer
AT wumin identificationofpyroptosisrelatedlncrnasforconstructingaprognosticmodelandtheircorrelationwithimmuneinfiltrationinbreastcancer
AT wuyiping identificationofpyroptosisrelatedlncrnasforconstructingaprognosticmodelandtheircorrelationwithimmuneinfiltrationinbreastcancer
AT renyuping identificationofpyroptosisrelatedlncrnasforconstructingaprognosticmodelandtheircorrelationwithimmuneinfiltrationinbreastcancer
AT zhangqi identificationofpyroptosisrelatedlncrnasforconstructingaprognosticmodelandtheircorrelationwithimmuneinfiltrationinbreastcancer